Prof. Dr. GÜNAY YETİK ANACAK

Yayın Ağı

SCI, SSCI ve AHCI İndekslerine Giren Dergilerde Yayınlanan Makaleler

Osthole improves erectile function by increasing endogenous H2S production

Alan-Albayrak E., Pinilla E., Comerma-Steffensen S., Erac Y., Yetik-Anacak G. Y., Simonsen U., et al.

European Journal of Pharmacology , cilt.997, 2025 (SCI-Expanded)

Borax pentahydrate as a promising boron-based angiogenesis inhibitor

Ulus G., Özbek E., Yılmaz H., Keselik E., Sarıcaoğlu M., Akyol Bahçeci S., et al.

Journal of Trace Elements in Medicine and Biology , cilt.89, 2025 (SCI-Expanded)

Pharmacological modulation of vascular ageing: A review from VascAgeNet

Roth L., Dogan S., Tuna B. G., Aranyi T., Benitez S., Borrell-Pages M., et al.

AGEING RESEARCH REVIEWS , cilt.92, 2023 (SCI-Expanded) Sürdürülebilir Kalkınma

The Effects of Novel Triazolopyrimidine Derivatives on H2S Production in Lung and Vascular Tonus in Aorta

Ozbek E. N., Istanbullu H., Kizrak U., Albayrak E. A., Sevin G., Yetik-Anacak G. Y.

PHARMACOLOGY , cilt.108, sa.6, ss.530-539, 2023 (SCI-Expanded)

Vascular ageing: moving from bench towards bedside

Climie R. E., Alastruey J., Mayer C. C., Schwarz A., Laucyte-Cibulskiene A., Voicehovska J., et al.

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY , cilt.30, sa.11, ss.1101-1117, 2023 (SCI-Expanded)

Relaxation mechanisms of chloroform root extracts of Prangos heyniae and Prangos uechtritzii on mouse corpus cavernosum

ALAN E., Albayrak G., SEVİN G., YETİK ANACAK G. Y., BAYKAN ÖZTÜRK Ş.

ANDROLOGIA , cilt.54, sa.11, 2022 (SCI-Expanded)

H2S releasing sodium sulfide protects against pulmonary hypertension by improving vascular responses in monocrotaline-induced pulmonary hypertension

Turhan K., ALAN E., Yetik-Anacak G. Y., SEVİN G.

EUROPEAN JOURNAL OF PHARMACOLOGY , cilt.931, 2022 (SCI-Expanded)

Comparative evaluation of relaxant effects of three prangos species on mouse corpus cavernosum: Chemical characterization and the relaxant mechanisms of action of P. pabularia and (+)-oxypeucedanin

Sevin G., ALAN E., DEMİR S., Albayrak G., Demiroz T., YETİK ANACAK G. Y., et al.

JOURNAL OF ETHNOPHARMACOLOGY , cilt.284, 2022 (SCI-Expanded)

The role of resistin on metabolic syndrome-induced erectile dysfunction and the possible therapeutic effect of Boldine

Kara E., KAHRAMAN E., Dayar E., YETİK ANACAK G. Y., Demir O., Gidener S., et al.

ANDROLOGY , cilt.8, sa.6, ss.1728-1735, 2020 (SCI-Expanded)

Evaluation of Smoking and Other Tobacco Product Habits of Ege University Faculty of Health Sciences Students: A cross-sectional Survey Study

Uysal F. E., Gurgun A., HASSOY H., Guduk Z., Ciray N., ERGİN I., et al.

EUROPEAN RESPIRATORY JOURNAL , 2020 (SCI-Expanded)

The anti-angiogenic potential of (±) gossypol in comparison to suramin

Ulus G., KOPARAL A. S., Baysal K., YETİK ANACAK G. Y., KARABAY YAVAŞOĞLU N. Ü.

CYTOTECHNOLOGY , sa.6, ss.1537-1550, 2018 (SCI-Expanded)

Cycloartane-type sapogenol derivatives inhibit NFκB activation as chemopreventive strategy for inflammation-induced prostate carcinogenesis

DEBELEÇ BÜTÜNER B., Ozturk M. B., Tag O., Akgun I. H., YETİK ANACAK G. Y., Bedir E., et al.

STEROIDS , cilt.135, ss.9-20, 2018 (SCI-Expanded)

Do penile haemodynamics change in the presence of hydrogen sulphide (H2S) donor in metabolic syndrome-induced erectile dysfunction?

Dayar E., Kara E., YETİK ANACAK G. Y., HOCAOĞLU AKSAY N., BOZKURT O., Gidener S., et al.

ANDROLOGIA , cilt.50, sa.3, 2018 (SCI-Expanded)

The role of eNOS on the compensatory regulation of vascular tonus by H2S in mouse carotid arteries

ERTUNA E., Loot A. E., Fleming I., YETİK ANACAK G. Y.

NITRIC OXIDE-BIOLOGY AND CHEMISTRY , cilt.69, ss.45-50, 2017 (SCI-Expanded)

Hydrogen sulfide: A novel mechanism for the vascular protection by resveratrol under oxidative stress in mouse aorta

YETİK ANACAK G. Y., Sevin G., Ozzayim O., Dereli M. V., Ahmed A.

VASCULAR PHARMACOLOGY , cilt.87, ss.76-82, 2016 (SCI-Expanded)

Hydrogen sulfide compensates nitric oxide deficiency in murine corpus cavernosum

YETİK ANACAK G. Y., Dikmen A., Coletta C., Mitidieri E., Dereli M., Donnarumma E., et al.

PHARMACOLOGICAL RESEARCH , cilt.113, ss.38-43, 2016 (SCI-Expanded)

Diverse effects of taurine on vascular response and inflammation in GSH depletion model in rabbits

Ozsarlak-Sozer G., Sevin G., Ozgur H. H., YETİK ANACAK G. Y., Kerry Z.

EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES , cilt.20, sa.7, ss.1360-1372, 2016 (SCI-Expanded)

Resveratrol Stimulates Hydrogen Sulfide (H2S) Formation to Relax Murine Corpus Cavernosum

YETİK ANACAK G. Y., Dereli M. V., Sevin G., Ozzayim O., Erac Y., Ahmed A.

JOURNAL OF SEXUAL MEDICINE , cilt.12, sa.10, ss.2004-2012, 2015 (SCI-Expanded)

Gas what: NO is not the only answer to sexual function

YETİK ANACAK G. Y., Sorrentino R., Linder A. E., Murat N.

BRITISH JOURNAL OF PHARMACOLOGY , cilt.172, sa.6, ss.1434-1454, 2015 (SCI-Expanded)

Lacidipine has antiatherosclerotic effects independent of its actions on lipid metabolism and blood pressure

YETİK ANACAK G. Y., Ustunes L., YILMAZ Ö., Ergul A.

VASCULAR PHARMACOLOGY , cilt.53, sa.5-6, ss.193-199, 2010 (SCI-Expanded)

Heat shock protein 90 inhibitors attenuate LPS-induced endothelial hyperpermeability

Chatterjee A., Snead C., YETİK ANACAK G. Y., Antonova G., Zeng J., Catravas J. D.

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY , cilt.294, sa.4, 2008 (SCI-Expanded)

The effects of calcium channel blockers are not related to their chemical structure in the collar model of the rabbit

Yasa M., Kerry Z., REEL B., YETİK ANACAK G. Y., ERTUNA E., Ozer A.

JOURNAL OF INTERNATIONAL MEDICAL RESEARCH , cilt.35, sa.1, ss.59-71, 2007 (SCI-Expanded)

Nitric oxide and the endothelium: History and impact on cardiovascular disease

YETİK ANACAK G. Y., Catravas J. D.

VASCULAR PHARMACOLOGY , cilt.45, sa.5, ss.268-276, 2006 (SCI-Expanded)

Effects of hsp90 binding inhibitors on sGC-mediated vascular relaxation

YETİK ANACAK G. Y., Xia T., Dimitropoulou C., Venema R. C., Catravas J. D.

AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY , cilt.291, sa.1, 2006 (SCI-Expanded)

Interaction between the 90-kDa heat shock protein and soluble guanylyl cyclase: Physiological significance and mapping of the domains mediating binding

Papapetropoulos A., Zhou Z., Gerassimou C., YETİK ANACAK G. Y., Venema R., Roussos C., et al.

MOLECULAR PHARMACOLOGY , cilt.68, sa.4, ss.1133-1141, 2005 (SCI-Expanded)

Diverse effects of calcium channel blockers in the collar model

Kerry Z., Yasa M., Sevin G., REEL B., YETİK ANACAK G. Y., Özer A.

ACTA CARDIOLOGICA , cilt.60, sa.5, ss.493-499, 2005 (SCI-Expanded)

Comparison of electrochemical detection of acetylcholine-induced nitric oxide release (NO) and contractile force measurement of rabbit isolated carotid artery endothelium

KILINÇ M. E., YETİK ANACAK G. Y., Dalbasti T., Ozsoz M.

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS , cilt.28, sa.2, ss.345-354, 2002 (SCI-Expanded)

Antioxidant enzyme activities and total nitrite/nitrate levels in the collar model.: Effect of nicardipine

YILDIRIM SÖZMEN E., Kerry Z., Uysal F., ANACAK G. Y., Yasa M., Üstünes L., et al.

CLINICAL CHEMISTRY AND LABORATORY MEDICINE , cilt.38, sa.1, ss.21-25, 2000 (SCI-Expanded) Sürdürülebilir Kalkınma

Effects of treatment with FK409, a nitric oxide donor, on collar-induced intimal thickening and vascular reactivity

Yasa M., Kerry Z., YETİK ANACAK G. Y., Sevin G., REEL B., Özdemir N., et al.

EUROPEAN JOURNAL OF PHARMACOLOGY , cilt.374, sa.1, ss.33-39, 1999 (SCI-Expanded)

Effects of nicardipine on collar-induced intimal thickening and vascular reactivity in the rabbit

Kerry Z., Yasa M., Akpinar R., Sevin G., YETİK ANACAK G. Y., Tosun M., et al.

JOURNAL OF PHARMACY AND PHARMACOLOGY , cilt.51, sa.4, ss.441-447, 1999 (SCI-Expanded)

Diğer Dergilerde Yayınlanan Makaleler

Treatment Potential of Angiotensin Converting Enzyme Inhibitors in Alzheimers Disease: Pros and Con: Traditional Review

Başol C., Kerry Z., Yetik Anacak G. Y.

Türkiye Klinikleri Kardiyoloji Dergisi , cilt.11, 2022 (Hakemli Dergi)

Drug Repurposing in the Treatment of COVID-19

Soylu M., ÖZBEK E. N., YETİK ANACAK G. Y.

BEZMIALEM SCIENCE , ss.84-93, 2020 (ESCI)

Nonsteroidal anti-inflammatory drugs– What do we (not) know about them

Alexandrova r., alexandrov o., Beykov P., YETİK ANACAK G. Y., Krasilnikova J., Marinescu G., et al.

Merit Research Journal of Medicine and Medical Sciences , cilt.7, ss.412-421, 2019 (Hakemli Dergi)

Briefly about Anticancer Properties of Statins Biomed

Alexandrova r., Dinev D., Glavcheva M., Danova J., YETİK ANACAK G. Y., Krasilnikova J., et al.

Biomed J Sci Tech Res , cilt.17, sa.2, 2019 (Hakemli Dergi)

Investigation of changes in vWF expression in rabbit carotid artery collar model

ARUN M. Z., Sevin G., YETİK ANACAK G. Y., Gonen Korkmaz C., Ustunes L.

IZMIR DR BEHCET UZ COCUK HASTANESI DERGISI , cilt.8, sa.1, ss.37-42, 2018 (ESCI)

Fluvastatinin Tavşan Karotid Arteri Yaka Modelinde İntimal Kalınlaşma Üzerine Etkileri

ARUN M. Z., SEVİN G., YETİK ANACAK G. Y., AYLA Ş., oktem g., ustunes l.

Zeynep Kamil medical journal (Online) , cilt.49, ss.161-164, 2018 (Hakemli Dergi)

The role of Six Trans membrane protein of prostate STAMP Proteins in prostate cancer Relation with survival genes

KORKMAZ C., SEVİN G., GÖKÇE G., ARUN M. Z., YETİK ANACAK G. Y., varisli l., et al.

j. cell signalling , cilt.1, sa.2, ss.1000114, 2016 (Hakemli Dergi)

Methylglyoxal causes endothelial dysfunction: The role of endothelial nitric oxide synthase and amp-activated protein kinase

Turkseven S., ERTUNA E., Yetik-Anacak G. Y., Yasa M.

Journal of Basic and Clinical Physiology and Pharmacology , cilt.25, sa.1, ss.109-115, 2014 (Scopus)

Angiotensin, bradykinin and the endothelium

Dimitropoulou C., Chatterjee A., McCloud L., Yetik-Anacak G. Y., Catravas J.

Handbook of Experimental Pharmacology , cilt.176, sa.PART1, ss.255-294, 2006 (Scopus)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler

Pharmacological modulation of vascular ageing: A review from VascAgeNet

Anacak G. Y.

Final workshop of VascAgeNet, Riga, Letonya, 20 - 21 Mart 2024, (Yayınlanmadı)

Gas what! NO Is not the only answer for sexual functıon

Anacak G. Y.

27. Ulusal, 2. Uluslararası Farmakoloji Kongresi, Antalya, Türkiye, 23 - 26 Kasım 2023, ss.14-15, (Özet Bildiri)

A new target for neuroprotective effect of serotonin:H2S

ÖZBEK E. N., Belen N., YETİK ANACAK G. Y.

26th National 1st International Pharmacology Congress, 4 - 06 Kasım 2021, (Özet Bildiri)

THE ROLE OF HYDROGEN SULFIDE (H2S) IN THE VASOCONSTRICTIVE EFFECTS OF SEROTONIN (5-HT)

Belen N., Belen N., ÖZBEK E. N., YETİK ANACAK G. Y., Bakırcı H., Bakırcı H.

26th National 1st International Pharmacology Congress, Türkiye, 4 - 06 Kasım 2021, (Özet Bildiri)

The effect of New Synthesized Resveratrol Derivate H1 on angiogenesis

ÖZBEK E. N., İSTANBULLU H., TorresVargas J. A., Quesada A. R., YETİK ANACAK G. Y.

Cost Action, 5 - 06 Mart 2020, (Özet Bildiri)

The journey from ethnobotanical studies to pharmacologicaltarget: The effect of imperatorin and isoimperatorin on penile relaxation.

belen n., Demiröz t., DEMİR S., baykan ş., SEVİN G., YETİK ANACAK G. Y.

Cost Action Meeting, 5 - 06 Mart 2020, (Özet Bildiri)

Effect of CORM-2 Molecule on Vascular Tonus in Penile Tissue

Yılmaz S., YETİK ANACAK G. Y., ÖZŞARLAK SÖZER G.

Mutalig COST Action 15135, 5 - 06 Mart 2020, (Özet Bildiri)

Fare Penil Dokusunda Gevşetici Etki Gösteren Endemik Bir Bitki: Prangos uechtritzii BOISSHAUSSKN

ALAN E., ALBAYRAK G., SEVİN G., BAYKAN Ş., YETİK ANACAK G. Y.

25. ULUSAL FARMAKOLOJİ KONGRESİ, Aydın/Kuşadası, Türkiye, 4 - 07 Kasım 2019, (Özet Bildiri)

A new synthesized ache inhibitor induces H2S formation in the brain

Belen N., alançay e., SEVİN G., Parlar S., ALPTÜZÜN V., YETİK ANACAK G. Y.

MedChem2019, Catanzaro, İtalya, 13 - 15 Haziran 2019, (Tam Metin Bildiri)

Tracking the Oxypeucedanin: from ethnobotanical studies to pharmacological target

alançay e., Demiröz t., DEMİR S., belen n., SEVİN G., baykan ş., et al.

MuTaLig COST ACTION CA15135 3rd WG meeting 2019, Paris, Fransa, 23 - 24 Şubat 2019, (Tam Metin Bildiri)

1,4-Dihydropyridine-Benzylidenhydrazon Derived AChE Inhibitor Induces H2S Formation

SEVİN G., ALAN ALBAYRAK E., PARLAR ÇOŞKUN S., ÖZBEK E. N., kaya o., ALPTÜZÜN V., et al.

MuTaLig COST ACTION CA15135 3rd WG meeting 2019, Paris, Fransa, 23 - 24 Şubat 2019, ss.59, (Özet Bildiri)

A new target for an old natural molecule

YETİK ANACAK G. Y.

13th Workshop ”Biological Activity of Metals, Synthetic Compounds and Natural Products, Sofya, Bulgaristan, 19 - 21 Kasım 2018

A Merging Strategy Application: Tacrine-Benzylidenehydrazone Hybrids as Potent ChE Inhibitors with Metal Binding and Neuroprotective Properties

BAYRAKTAR G., ERDOĞAN M. A., PARLAR ÇOŞKUN S., SAYLAM M., ARMAGAN G., YETİK ANACAK G. Y., et al.

MuTaLig COST ACTION CA15135 Annual meeting 2018, 18 - 19 Ekim 2018, (Özet Bildiri)

A Merging Strategy Application: Tacrine-Benzylidenehydrazone Hybrids as Potent ChE Inhibitors with Metal Binding and Neuroprotective Properties

BAYRAKTAR G., ERDOĞAN M. A., PARLAR ÇOŞKUN S., SAYLAM M., ARMAGAN G., YETİK ANACAK G. Y., et al.

MuTaLig COST ACTION CA15135 3rd Annual Meeting 2018, Valletta, Malta, 18 - 19 Ekim 2018, ss.40-41, (Özet Bildiri)

Effects of Prangos heyniae H.DumanM.F.Watson Roots on Erectile Function

ALBAYRAK G., Alançay E., SEVİN G., YETİK ANACAK G. Y., BAYKAN Ş.

4th International Symposium on Medicinal and Aromatic Plants, İzmir, Türkiye, 2 - 04 Ekim 2018, (Özet Bildiri)

Effect Of The Triazolopyrimidine Compound On Endogenous H2s Levels In Lung Tissue Homogenates: A Scaffold Hopping Application On Resveratrol Derivatives

İSTANBULLU H., Alançay E., Kızrak Ü., ÇOBAN G., SEVİN G., YETİK ANACAK G. Y.

Xxv Efmc International Symposium On Medicinal Chemistry, 2 - 06 Eylül 2018, (Özet Bildiri)

. Effect of the triazolopyrimidine compound on endogenous H2S levels in lung tissue homogenates: A scaffold hopping application on resveratrol derıvatıves.

İSTANBULLU H., Alançay E., Kızrak Ü., ÇOBAN G., SEVİN G., YETİK ANACAK G. Y.

. XXV International Symposium on Medicinal Chemistry (EFMC-ISMC), 2 - 06 Eylül 2018, (Özet Bildiri)

Prangos pabularia Lindl. erektil disfonksiyon için çözüm olabilir mi?

BAYKAN Ş., SEVİN G., Alançay E., ALBAYRAK G., YETİK ANACAK G. Y.

XXIII. Bitkisel İlaç hammaddeleri Toplantısı (BİHAT), Türkiye, 9 - 12 Nisan 2018, (Özet Bildiri)

H2S formation in liver is induced by zmp17 and zmp20

YETİK ANACAK G. Y., Alançay E., SEVİN G.

112. International Symposium on Pharmaceutical Sciences (ISOPS), 26 - 29 Haziran 2018, (Özet Bildiri)

The Effect of Prangos pabularia Lindl. on erectile dysfunction associated with H2S

BAYKAN Ş., SEVİN G., Alançay E., ALBAYRAK G., YETİK ANACAK G. Y.

12th. International Symposium on Pharmaceutical Sciences (ISOPS), Türkiye, 26 - 29 Haziran 2018, (Özet Bildiri)

Effects of prangos uechtritzii BoissHausskn roots on erectile disfunction

ALBAYRAK G., Alançay E., SEVİN G., YETİK ANACAK G. Y., BAYKAN Ş.

1st International Traditional and Complementary Medicine Congress (ITCMC), İstanbul, Türkiye, 19 - 21 Nisan 2018, (Özet Bildiri)

Design and synthesis of 1,4-dihydropyridine derivatives aspotential cholinesterase inhibitorswith H2S releasing group

BAYRAKTAR G., ALPTÜZÜN V., YETİK ANACAK G. Y., BOLOGNESI M. L., İSTANBULLU H.

FIRST BRAZIL-BOLOGNAALZHEIMER’S DRUGDISCOVERY (B2AlzD2)WORKSHOP, Bologna, İtalya, 23 Mart 2018, (Özet Bildiri)

Hydrogen sulfide: a candidate multitarget ligand for cardiovascular diseases

YETİK ANACAK G. Y., SEVİN G., ERAÇ Y.

Hydrogen sulfide: a candidate multitarget ligand for cardiovascular diseases, 15 - 16 Mart 2018, (Özet Bildiri)

Hydrogen sulfide: a candidate multitarget ligand for cardiovascular diseases.

YETİK ANACAK G. Y., SEVİN G., ERAÇ Y.

MuTaLig COST ACTION CA15135 Second WG meeting 2018, Tenerife, İspanya, 15 - 16 Mart 2018, (Özet Bildiri)

Hydrogen sulfide: a candidate multitarget ligand for cardiovascular diseases

YETİK ANACAK G. Y., SEVİN G., ERAÇ Y.

Second WG Meeting COST ACTION CA15135, 15 - 16 Mart 2018, (Özet Bildiri)

A new multitargeted drug candidate in Alzheimer disease: 1,4-dihydropyridine-benzylidenhydrazon derived AChE inhibitor

SEVİN G., Alançay E., Yılmaz S., ALPTÜZÜN V., YETİK ANACAK G. Y.

Second WG Meeting COST ACTION CA15135, Multi-target paradigm for innovative ligand identification in the drug discovery process (MuTaLig), 15 - 16 Mart 2018, (Özet Bildiri)

Resveratrol analog induces hydrogen sulfide formation and vasorelaxation

alançay e., SEVİN G., yılmaz s., barış e., Jakopin Z., Tomasic T., et al.

A bridge between EpiChemBio and MuTaLig COST Actions, 22 - 24 Ekim 2017, ss.71, (Özet Bildiri)

gaz formundaki nörotransmitterlerde güncel durum

YETİK ANACAK G. Y.

farmakoloji, Trabzon, Türkiye, 17 - 20 Ekim 2017, ss.72-74, (Tam Metin Bildiri)

Yeni sentezlenen resveratrol türevleri fare aortasında gevşemeye ve hidrojen sülfit oluşumuna neden olurlar

Alançay E., SEVİN G., Yılmaz S., Ziga J., Tihomir T., YETİK ANACAK G. Y.

24. Ulusal Farmakoloji Kongresi, 7. Klinik Toksikoloji Sempozyumu, 8. Klinik Farmakoloji Sempozyumu, Türkiye, 17 - 20 Ekim 2017, (Özet Bildiri)

Alzheimer Tedavisinde Çok Hedefli Bir İlaç Adayı: 1,4-Dihidropiridin-Benzilidenhidrazon Türevi Asetilkolin Esteraz İnhibitörü

SEVİN G., ALANÇAY E., YILMAZ S., PARLAR ÇOŞKUN S., ALPTÜZÜN V., KERRY Z., et al.

24. Ulusal Farmakoloji Kongresi, Trabzon, Türkiye, 17 - 20 Ekim 2017, ss.243, (Özet Bildiri)

New drug candidates targeting hydrogen sulfide Poly Pharmacology expanding paul Ehrlich s magic bullet concept

YETİK ANACAK G. Y., ozzayim o., dereli m. v., SEVİN G.

1st work group meeting Cost action CA15135, Multitaget paradigm for innovative ligand identification in the drug discovery process (MuTaLig), 19 - 20 Kasım 2016, (Özet Bildiri)